These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques. Molyneux PD; Tofts PS; Fletcher A; Gunn B; Robinson P; Gallagher H; Moseley IF; Barker GJ; Miller DH J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):42-7. PubMed ID: 9667559 [TBL] [Abstract][Full Text] [Related]
9. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Warach S; Pettigrew LC; Dashe JF; Pullicino P; Lefkowitz DM; Sabounjian L; Harnett K; Schwiderski U; Gammans R Ann Neurol; 2000 Nov; 48(5):713-22. PubMed ID: 11079534 [TBL] [Abstract][Full Text] [Related]
10. Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin-echo, rapid relaxation-enhanced, and fast-FLAIR sequences. Filippi M; Rocca MA; Gasperini C; Sormani MP; Bastianello S; Horsfield MA; Pozzilli C; Comi G AJNR Am J Neuroradiol; 1999 Jan; 20(1):133-7. PubMed ID: 9974068 [TBL] [Abstract][Full Text] [Related]
11. Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis. Radue EW; O'Connor P; Polman CH; Hohlfeld R; Calabresi P; Selmaj K; Mueller-Lenke N; Agoropoulou C; Holdbrook F; de Vera A; Zhang-Auberson L; Francis G; Burtin P; Kappos L; Arch Neurol; 2012 Oct; 69(10):1259-69. PubMed ID: 22751847 [TBL] [Abstract][Full Text] [Related]
12. Intraobserver and interobserver variability in measuring changes in lesion volume on serial brain MR images in multiple sclerosis. Filippi M; Rovaris M; Sormani MP; Horsfield MA; Rocca MA; Capra R; Prandini F; Comi G AJNR Am J Neuroradiol; 1998 Apr; 19(4):685-7. PubMed ID: 9576654 [TBL] [Abstract][Full Text] [Related]
13. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Matthews PM; Pioro E; Narayanan S; De Stefano N; Fu L; Francis G; Antel J; Wolfson C; Arnold DL Brain; 1996 Jun; 119 ( Pt 3)():715-22. PubMed ID: 8673485 [TBL] [Abstract][Full Text] [Related]
14. Subject movement during multislice interleaved MR acquisitions: prevalence and potential effect on MRI-derived brain pathology measurements and multicenter clinical trials of therapeutics for multiple sclerosis. Gedamu EL; Gedamu A J Magn Reson Imaging; 2012 Aug; 36(2):332-43. PubMed ID: 22581754 [TBL] [Abstract][Full Text] [Related]
15. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773 [TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. Moraal B; Pohl C; Uitdehaag BM; Polman CH; Edan G; Freedman MS; Hartung HP; Kappos L; Miller DH; Montalban X; Lanius V; Sandbrink R; Barkhof F Arch Neurol; 2009 Nov; 66(11):1345-52. PubMed ID: 19901165 [TBL] [Abstract][Full Text] [Related]